期刊文献+

尿酸对男性急性冠状动脉综合征患者PCI术后抗血小板效应的影响 被引量:1

Effect of uric acid on antiplatelet effect in male patients with acute coronary syndrome after PCI
下载PDF
导出
摘要 目的探讨尿酸对男性急性冠状动脉综合征(ACS)患者经皮冠状动脉介入(PCI)术后抗血小板效应的影响。方法按照尿酸水平,将2018年1-12月在该院行PCI术的160例男性ACS患者分为高尿酸组(72例)与正常尿酸组(88例)。PCI术后所有患者均口服硫酸氢氯吡格雷片(每次75 mg,每日1次)和阿司匹林片(每次100 mg,每日1次)。服药1周后采用VerifyNow血小板功能检测仪测定2组的血小板聚集率,计算血小板高反应性(血小板聚集率>46%)。采用血栓弹力图仪测定2组的花生四烯酸抑制率及二磷酸腺苷抑制率。观察2组主要心血管不良事件的发生情况。结果高尿酸组三酰甘油及肌酐水平均明显高于正常尿酸组(P<0.05),高密度脂蛋白胆固醇水平明显低于正常尿酸组(P<0.05)。高尿酸组的血小板聚集率[(43.58±7.22)%]及血小板高反应性[56.94%(41/72)]均明显高于正常尿酸组[(34.17±5.65)%、20.45%(18/88)],差异有统计学意义(P<0.05)。高尿酸组的花生四烯酸抑制率[(48.25±8.87)%]及二磷酸腺苷抑制率[(35.19±6.22)%]均明显低于正常尿酸组[(66.32±10.43)%、(60.44±9.17)%],差异有统计学意义(P<0.05)。高尿酸组的主要心血管不良事件发生率[16.67%(12/72)]明显高于正常尿酸组[4.55%(4/88)],差异有统计学意义(P<0.05)。结论高尿酸男性ACS患者PCI术后抗血小板作用减弱,效应降低。 Objective To investigate the effect of uric acid on antiplatelet effect in male patients with acute coronary syndrome(ACS)after percutaneous coronary intervention(PCI).Methods According to the level of uric acid,160 male ACS patients undergoing PCI in the hospital from January to December 2018 were divided into high uric acid group(72 cases)and normal uric acid group(88 cases).All patients were given clopidogrel tablets(75 mg/time,1 time/d)and aspirin tablets(100 mg/time,1 time/d)after PCI.The platelet aggregation rate of the two groups was measured by VerifyNow platelet function tester one week after taking the medicine,and the platelet high reactivity(platelet aggregation rate>46%)was calculated.The inhibition rates of arachidonic acid and adenosine diphosphate were measured by thromboelastography.The main adverse cardiovascular events were observed in two groups.Results The levels of triacylglycerol and creatinine in high uric acid group were significantly higher than those in normal uric acid group(P<0.05),and the levels of HDL-C were significantly lower than those in normal uric acid group(P<0.05).The platelet aggregation rate[(43.58±7.22)%vs.(34.17±5.65)%]and platelet hyperresponsiveness[56.94%(41/72)vs.20.45%(18/88)]of high uric acid group was significantly higher than that of normal uric acid group(P<0.05).The inhibition rate of arachidonic acid[(48.25±8.87)%vs.(66.32±10.43)%]and the inhibition rate of adenosine diphosphate[(35.19±6.22)%vs.(60.44±9.17)%]of high uric acid group was significantly lower than that of normal uric acid group(P<0.05).The incidence of main adverse cardiovascular events[16.67%(12/72)vs.4.55%(4/88)]in high uric acid group was significantly higher than that of normal uric acid group(P<0.05).Conclusion The antiplatelet effect was weakened after PCI in male ACS patients with high uric acid.
作者 李会文 邵彬 LI Huiwen;SHAO Bin(Department of Emergency,Shaanxi Provincial General Hospital of Armed Police,Xi′an,Shaanxi 710000,China;Department of Quality Management,Shaanxi Provincial General Hospital of Armed Police,Xi′an,Shaanxi 710000,China)
出处 《检验医学与临床》 CAS 2020年第15期2172-2174,2178,共4页 Laboratory Medicine and Clinic
关键词 急性冠状动脉综合征 经皮冠状动脉介入 尿酸 男性 抗血小板治疗 acute coronary syndrome percutaneous coronary intervention uric acid male antiplatelet therapy
  • 相关文献

参考文献13

二级参考文献97

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 3Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 4Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 5Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 6Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 7CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 8Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 9Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 10Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.

共引文献5120

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部